LIFEVANTAGE CORP Operating Leases, Future Minimum Payments Due, Next Twelve Months
LIFEVANTAGE CORP (LFVN) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $2.87 million as of 2019-06-30, per its 10-K filed 2020-08-18.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2020-08-18
- 2019-06-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $2.87M.
- 2018-06-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $2.81M.
- 2017-06-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $2.61M.
- 2016-06-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $2.59M.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2019-06-30 | $2.87M 10-K · filed 2020-08-18 |
| 2018-06-30 | $2.81M 10-K · filed 2018-08-15 |
| 2017-06-30 | $2.61M 10-K · filed 2017-09-07 |
| 2016-06-30 | $2.59M 10-K · filed 2016-12-12 |
| 2015-06-30 | $2.43M 10-K · filed 2015-09-01 |
| 2014-06-30 | $2.32M 10-K · filed 2014-09-10 |
| 2013-06-30 | $2.34M 10-K · filed 2013-09-12 |
| 2012-06-30 | $626.04K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |